Literature DB >> 8388302

Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells.

A J Petros1, R G Bogle, J D Pearson.   

Abstract

Propofol, an intravenous anaesthetic agent, causes marked vasodilatation in vivo. In the present study the effects of propofol on the release of nitric oxide (NO) from vascular endothelial cells was determined in vitro. Application of propofol to co-cultures of porcine aortic endothelial and smooth muscle cells resulted in a rapid increase in cyclic GMP formation. This increase was significantly inhibited following pretreatment of the cells with either NG-nitro-L-arginine (L-NOARG) or in the presence of haemoglobin. When applied to smooth muscle cells alone, propofol did not result in an increase in cyclic GMP levels. These results demonstrate that propofol stimulates the production and release of NO from cultured endothelial cells and suggest that the vasodilatation and hypotension observed when propofol is given in vivo may be due to NO release.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388302      PMCID: PMC2175593          DOI: 10.1111/j.1476-5381.1993.tb13523.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

Review 1.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

Review 2.  Cyclic GMP synthesis and function.

Authors:  S A Waldman; F Murad
Journal:  Pharmacol Rev       Date:  1987-09       Impact factor: 25.468

3.  Action of calcitonin gene-related peptide upon bovine vascular endothelial and smooth muscle cells grown in isolation and co-culture.

Authors:  D C Crossman; M R Dashwood; S D Brain; J McEwan; J D Pearson
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

4.  Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells.

Authors:  R G Bogle; S B Coade; S Moncada; J D Pearson; G E Mann
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

Review 5.  Some studies on the properties of the intravenous anaesthetic, propofol ('Diprivan')--a review.

Authors:  R M Grounds; M Morgan; J Lumley
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

6.  Effects of propofol and thiopental in isolated rat aorta and pulmonary artery.

Authors:  W K Park; C Lynch; R A Johns
Journal:  Anesthesiology       Date:  1992-11       Impact factor: 7.892

  6 in total
  13 in total

1.  Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.

Authors:  J P De La Cruz; M V Páez; J A Carmona; F S De La Cuesta
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Molecular interactions between general anesthetics and the 5HT2B receptor.

Authors:  Felipe Matsunaga; Lu Gao; Xi-Ping Huang; Jeffery G Saven; Bryan L Roth; Renyu Liu
Journal:  J Biomol Struct Dyn       Date:  2013-12-23

3.  Effects of propofol on the leukocyte nitric oxide pathway: in vitro and ex vivo studies in surgical patients.

Authors:  J A González-Correa; E Cruz-Andreotti; M M Arrebola; J A López-Villodres; M Jódar; J P De La Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-07       Impact factor: 3.000

4.  The incidence, significance, and management of accidental intra-arterial injection: a narrative review.

Authors:  Andrew Lokoff; Jason T Maynes
Journal:  Can J Anaesth       Date:  2019-03-15       Impact factor: 5.063

5.  Effectiveness of intravenous dexamethasone versus propofol for pain relief in the migraine headache: a prospective double blind randomized clinical trial.

Authors:  Hassan Soleimanpour; Rouzbeh Rajaei Ghafouri; Aliakbar Taheraghdam; Dawood Aghamohammadi; Sohrab Negargar; Samad E J Golzari; Mohsen Abbasnezhad
Journal:  BMC Neurol       Date:  2012-09-29       Impact factor: 2.474

6.  The effect of intravenous dexamethasone and lidocaine on propofol-induced vascular pain: a randomized double-blinded placebo-controlled trial.

Authors:  Shireen Ahmad; Gildasio S De Oliveira; Paul C Fitzgerald; Robert J McCarthy
Journal:  Pain Res Treat       Date:  2013-07-15

7.  Quinapril decreases antifibrinolytic and prooxidative potential of propofol in arterial thrombosis in hypertensive rats.

Authors:  Marzena Wojewodzka-Zelezniakowicz; Wioleta Kisiel; Karol Kramkowski; Anna Gromotowicz-Poplawska; Agnieszka Zakrzeska; Adrian Stankiewicz; Patrycjusz Kolodziejczyk; Janusz Szemraj; Jerzy Robert Ladny; Ewa Chabielska
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-05-11       Impact factor: 1.636

8.  Angiotensin-converting enzyme inhibitors attenuate propofol-induced pro-oxidative and antifibrinolytic effect in human endothelial cells.

Authors:  Marzena Wojewodzka-Zelezniakowicz; Anna Gromotowicz-Poplawska; Wioleta Kisiel; Emilia Konarzewska; Janusz Szemraj; Jerzy Robert Ladny; Ewa Chabielska
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017-01       Impact factor: 1.636

9.  Anti-inflammatory effects of propofol during cardiopulmonary bypass: a pilot study.

Authors:  A Samir; N Gandreti; M Madhere; A Khan; M Brown; V Loomba
Journal:  Ann Card Anaesth       Date:  2015 Oct-Dec

10.  Acute complete uterine inversion after controlled cord traction of placenta following vaginal delivery: a case report.

Authors:  Shi Sum Poon; Chung Shen Chean; Philip Barclay; Adel Soltan
Journal:  Clin Case Rep       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.